187 related articles for article (PubMed ID: 16650962)
1. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A
Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962
[TBL] [Abstract][Full Text] [Related]
2. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
Tobias DH; Eng C; McCurdy LD; Kalir T; Mandelli J; Dottino PR; Cohen CJ
Gynecol Oncol; 2000 Aug; 78(2):148-51. PubMed ID: 10926794
[TBL] [Abstract][Full Text] [Related]
3. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.
Hornreich G; Beller U; Lavie O; Renbaum P; Cohen Y; Levy-Lahad E
Gynecol Oncol; 1999 Nov; 75(2):300-4. PubMed ID: 10525392
[TBL] [Abstract][Full Text] [Related]
4. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E
Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
[TBL] [Abstract][Full Text] [Related]
5. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
Roa BB; Boyd AA; Volcik K; Richards CS
Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
[TBL] [Abstract][Full Text] [Related]
6. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
Oddoux C; Struewing JP; Clayton CM; Neuhausen S; Brody LC; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192
[TBL] [Abstract][Full Text] [Related]
7. High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.
Beller U; Halle D; Catane R; Kaufman B; Hornreich G; Levy-Lahad E
Gynecol Oncol; 1997 Nov; 67(2):123-6. PubMed ID: 9367693
[TBL] [Abstract][Full Text] [Related]
8. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
Neuhausen S; Gilewski T; Norton L; Tran T; McGuire P; Swensen J; Hampel H; Borgen P; Brown K; Skolnick M; Shattuck-Eidens D; Jhanwar S; Goldgar D; Offit K
Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.
Gershoni-Baruch R; Dagan E; Fried G; Kepten I; Robinson E
Eur J Hum Genet; 1999; 7(7):833-6. PubMed ID: 10573018
[TBL] [Abstract][Full Text] [Related]
10. Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.
Foulkes WD; Wong N; Brunet JS; Bégin LR; Zhang JC; Martinez JJ; Rozen F; Tonin PN; Narod SA; Karp SE; Pollak MN
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2465-9. PubMed ID: 9815648
[TBL] [Abstract][Full Text] [Related]
11. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
[TBL] [Abstract][Full Text] [Related]
12. Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient.
Randall TC; Bell KA; Rebane BA; Rubin SC; Boyd J
Gynecol Oncol; 1998 Sep; 70(3):432-4. PubMed ID: 9790802
[TBL] [Abstract][Full Text] [Related]
13. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
[TBL] [Abstract][Full Text] [Related]
14. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.
FitzGerald MG; MacDonald DJ; Krainer M; Hoover I; O'Neil E; Unsal H; Silva-Arrieto S; Finkelstein DM; Beer-Romero P; Englert C; Sgroi DC; Smith BL; Younger JW; Garber JE; Duda RB; Mayzel KA; Isselbacher KJ; Friend SH; Haber DA
N Engl J Med; 1996 Jan; 334(3):143-9. PubMed ID: 8531968
[TBL] [Abstract][Full Text] [Related]
15. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study.
Armes JE; Egan AJ; Southey MC; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
Cancer; 1998 Dec; 83(11):2335-45. PubMed ID: 9840533
[TBL] [Abstract][Full Text] [Related]
16. [Mutations in the BRCA1 gene in young Spanish women with breast cancer].
Díez Gibert O; del Río E; Domènech M; Hernández EM; Sanz J; Brunet J; Alonso MC; Baiget M
Med Clin (Barc); 1999 Jan; 112(2):51-4. PubMed ID: 10065429
[TBL] [Abstract][Full Text] [Related]
17. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
Ursin G; Henderson BE; Haile RW; Pike MC; Zhou N; Diep A; Bernstein L
Cancer Res; 1997 Sep; 57(17):3678-81. PubMed ID: 9288771
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 germline mutations in women with uterine serous papillary carcinoma.
Lavie O; Hornreich G; Ben Arie A; Renbaum P; Levy-Lahad E; Beller U
Obstet Gynecol; 2000 Jul; 96(1):28-32. PubMed ID: 10862837
[TBL] [Abstract][Full Text] [Related]
19. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls.
Muto MG; Cramer DW; Tangir J; Berkowitz R; Mok S
Cancer Res; 1996 Mar; 56(6):1250-2. PubMed ID: 8640808
[TBL] [Abstract][Full Text] [Related]
20. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.
Drucker L; Stackievitz R; Shpitz B; Yarkoni S
Anticancer Res; 2000; 20(1B):559-61. PubMed ID: 10769725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]